Concepedia

John Leighton

JL

29

Publications

4K

Citations

21

H-Index

1950

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

Dana-Farber Cancer Institute

Fred Hutch Cancer Center

Einstein Medical Center Philadelphia

United States Food and Drug Administration

John Leighton is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and public health.

Top concepts

Publications per year

1950–2024

29

Publications

29

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +11

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 336 citations · Full text

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Corey J. Langer, John Leighton, Robert L. Comis et al. · Journal of Clinical Oncology · 1995 · 303 citations

Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Robert G. Gish, Camillo Porta, Lucian Lazar et al. · Journal of Clinical Oncology · 2007 · 279 citations

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin H. Cohen, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2005 · 212 citations · Full text

Rows per page

1–5 of 29